ArticleTrials2026
Effectiveness of patient-reported outcome-based symptom monitoring after prostate cancer surgery: protocol for a multicenter, randomized controlled trial.
Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionSurgery remains a primary treatment modality for prostate cancer. However, patients often experience a substantial burden of postoperative symptoms, which can significantly delay recovery and negatively impact quality of life. Patient-reported outcome (PRO)-based symptom management has emerged as a promising approach to support patient-centered care. Despite its growing importance, there is a lack of clinical trial evidence evaluating early postoperative symptom management in prostate cancer patients. We propose a multicenter randomized controlled trial to assess the effectiveness of a PRO-based symptom monitoring program with threshold-triggered alerts and clinician responses in promoting postoperative recovery in this population.
methodsThis study will enroll 144 patients with prostate cancer across three hospitals. Participants will be randomly assigned in a 1:1 ratio to either the intervention or control group. The intervention group will receive PRO-based symptom monitoring, whereby specialist clinicians will intervene when scores for target symptoms-pain, fatigue, disturbed sleep, drowsiness, and dry mouth-reach a predefined threshold (score ≥ 4). The control group will receive standard postoperative care without PRO-triggered alerts. Symptom data will be collected using the M.D. Anderson Symptom Inventory at baseline (3 days before surgery) and on postoperative days 1, 2, 3, 5, 7, 14, 28, 42, and 90. The primary outcome-the number of symptom threshold events-will be compared between groups using a t-test. DISCUSSION: This trial aims to investigate early-phase postoperative symptom management in patients undergoing prostate cancer surgery. Specifically, it will evaluate the efficacy and safety of a WeChat-based symptom management system in postoperative care. TRIALS REGISTRATION: This trial was registered in the Chinese Clinical Trial Registry (ChiCTR2400082090) on 20 March 2024, and the registration details are available at https://www.chictr.org.cn/showproj.html?proj=214038.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.